Literature DB >> 14185658

LAEVADOSIN IN TREATMENT OF DUCHENNE TYPE OF MUSCULAR DYSTROPHY: PRELIMINARY RESULTS OF A DOUBLE-BLIND CONTROLLED TRIAL.

J M PEARCE, S S GUBBAY, J HARDY, R J PENNINGTON, D J NEWELL, J N WALTON.   

Abstract

Entities:  

Keywords:  ADOLESCENCE; CHILD; CLINICAL RESEARCH; CREATINE KINASE; DRUG THERAPY; ENZYME TESTS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; MUSCULAR DYSTROPHY; NUCLEOSIDES; NUCLEOTIDES; PROGNOSIS; STATISTICS

Mesh：

Substances：

Year:  1964        PMID： 14185658      PMCID： PMC1816923          DOI： 10.1136/bmj.2.5414.915

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  6 in total

1.  TREATMENT OF MUSCULAR DYSTROPHY WITH A NUCLEOTIDES- NUCLEOSIDES COMBINATION.

Authors:  K E GUEST; W D MCLAY
Journal:  Br J Clin Pract       Date:  1964-07

2.  [On the treatment of muscular diseases by anabolic steroids. I. Metabolic studies].

Authors:  N HANTSCHMANN; D MATZELT; H G MERTENS; H NOWAKOWSKI
Journal:  Dtsch Med Wochenschr       Date:  1962-12-21       Impact factor: 0.628

3.  A trial of therapy by nucleosides and nucleotides in muscular dystrophy.

Authors:  W H THOMSON; K E GUEST
Journal:  J Neurol Neurosurg Psychiatry       Date:  1963-04       Impact factor: 10.154

4.  Methandrostenolone and nandrolone decanoate in muscular dystrophy; a controlled trial.

Authors:  D D BARWICK; D J NEWELL; J N WALTON
Journal:  Neurology       Date:  1963-01       Impact factor: 9.910

5.  [The use of methylandrostendiol(neosteron) in the treatment of progressive muscular dystrophy].

Authors:  G BEKENY; F KRAFT; S LANG
Journal:  Psychiatr Neurol (Basel)       Date:  1959-04

6.  [The effects of anabolizing steroids on creatine metabolism in progressive muscular dystrophy].

Authors:  E DE TONI
Journal:  Clin Pediatr (Bologna)       Date:  1959-06
  6 in total
  4 in total

1.  LAEVADOSIN IN MUSCULAR DYSTROPHY.

Authors:  J N WALTON; S S GUBBAY; P HUDGSON; D J NEWELL
Journal:  Br Med J       Date:  1965-08-28

2.  LAEVADOSIN IN MUSCULAR DYSTROPHY.

Authors:  W H THOMSON
Journal:  Br Med J       Date:  1965-09-11

3.  The Early Use of Blinding in Therapeutic Clinical Research of Neurological Disorders.

Authors:  Matthew B Jensen; Erika L Janik; Andrew J Waclawik
Journal:  J Neurol Res Ther       Date:  2016-01-05

4.  Adenosine 5 -triphosphate--creatine phosphotransferase from dystrophic mouse skeletal muscle. A genetic lesion associated with the catalytic-site thiol group.

Authors:  B T Hooton; D C Watts
Journal:  Biochem J       Date:  1966-09       Impact factor: 3.857
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.